Vanguard Group Inc Gilead Sciences, Inc. Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 115,528,392 shares of GILD stock, worth $12.9 Billion. This represents 0.19% of its overall portfolio holdings.

Number of Shares
115,528,392
Previous 115,342,884 0.16%
Holding current value
$12.9 Billion
Previous $9.67 Billion 10.38%
% of portfolio
0.19%
Previous 0.18%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$83.95 - $97.9 $15.6 Million - $18.2 Million
185,508 Added 0.16%
115,528,392 $10.7 Billion
Q3 2024

Nov 13, 2024
BUY
$66.59 - $83.99 $5.4 Million - $6.81 Million
81,110 Added 0.07%
115,342,884 $9.67 Billion
Q2 2024

Aug 13, 2024
BUY
$63.15 - $72.88 $33.4 Million - $38.6 Million
529,199 Added 0.46%
115,261,774 $7.91 Billion
Q1 2024

May 10, 2024
BUY
$71.58 - $87.29 $208 Million - $254 Million
2,910,147 Added 2.6%
114,732,575 $8.4 Billion
Q4 2023

Feb 14, 2024
BUY
$73.27 - $83.09 $10.1 Million - $11.5 Million
137,854 Added 0.12%
111,822,428 $9.06 Billion
Q3 2023

Nov 14, 2023
SELL
$73.94 - $80.67 $125 Million - $136 Million
-1,684,076 Reduced 1.49%
111,684,574 $8.37 Billion
Q2 2023

Aug 14, 2023
BUY
$76.01 - $86.7 $30 Million - $34.2 Million
394,253 Added 0.35%
113,368,650 $8.74 Billion
Q1 2023

Jul 14, 2023
BUY
$77.31 - $88.08 $129,107 - $147,093
1,670 Added 0.0%
112,974,397 $9.37 Billion
Q1 2023

May 15, 2023
BUY
$77.31 - $88.08 $72.2 Million - $82.3 Million
934,403 Added 0.83%
112,972,727 $9.37 Billion
Q4 2022

Feb 10, 2023
SELL
$62.32 - $89.47 $3.05 Million - $4.38 Million
-48,947 Reduced 0.04%
112,038,324 $9.62 Billion
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $101 Million - $115 Million
1,691,194 Added 1.53%
112,087,271 $6.91 Billion
Q2 2022

Aug 12, 2022
BUY
$57.72 - $65.01 $276 Million - $311 Million
4,787,719 Added 4.53%
110,396,077 $6.82 Billion
Q1 2022

May 13, 2022
SELL
$57.92 - $72.58 $11.3 Million - $14.2 Million
-195,441 Reduced 0.18%
105,608,358 $6.28 Billion
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $38.8 Million - $44.1 Million
598,438 Added 0.57%
105,803,799 $7.68 Billion
Q3 2021

Nov 12, 2021
BUY
$67.69 - $73.03 $12.7 Million - $13.7 Million
187,419 Added 0.18%
105,205,361 $7.35 Billion
Q2 2021

Aug 13, 2021
BUY
$63.47 - $69.35 $6.67 Billion - $7.28 Billion
105,017,942 New
105,017,942 $7.23 Billion

Others Institutions Holding GILD

# of Institutions
2,101
Shares Held
987M
Call Options Held
8.73M
Put Options Held
9.63M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $140B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email